Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration

Marina Pizzi, Alessandra Valerio, Virginia Arrighi, Marco Belloni, Antonella Alberici, PierFranco Spano, Maurizio Memo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

1. We investigated the possible involvement of tau proteins in the neurotoxic process activated by glutamate using the oligonucleotide antisense strategy. 2. We found that pretreatment of granule cells with an antisense oligonucleotide of the tau gene completely prevented the increase in tau immunoreactivity induced by glutamate. 3. A significant amount of the tau antisense oligonucleotide (about 1 to 2% of total) was taken up by the cells and remained stable in the cells for at least 60 min. A dose-response study revealed that 25 μM tau antisense oligonucleotide was the most efficacious concentration in terms of prevention of glutamate-induced tau immunoreactivity increases, without affecting basal tau expression. Higher concentrations of tau oligonucleotide antisense reduced tau immunoreactivity in control cells. 4. Significantly, the concentration-response curve of glutamate for inducing neuronal death in cells pretreated with tau antisense oligonucleotide showed a shift to the right compared to those obtained in untreated or tau sense oligonucleotide-treated cells. 5. Since inhibition of tau synthesis does not completely prevent but only decreases the neuronal sensitivity to glutamate, it is tempting to speculate that accumulation of tau within the neuron in response to glutamate represents one of the molecular risk factors lowering the safety margin of neurons to excitotoxic-induced injury.

Original languageEnglish
Pages (from-to)569-578
Number of pages10
JournalCellular and Molecular Neurobiology
Volume14
Issue number5
DOIs
Publication statusPublished - Oct 1994

Fingerprint

tau Proteins
Antisense Oligonucleotides
Glutamic Acid
Neurons
Oligonucleotides
Cell Death
Genes
Cells
Safety
Wounds and Injuries

Keywords

  • cytoskeleton
  • excitatory amino acids
  • neurodegeneration
  • phosphorylation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Genetics
  • Clinical Biochemistry
  • Cell Biology

Cite this

Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. / Pizzi, Marina; Valerio, Alessandra; Arrighi, Virginia; Belloni, Marco; Alberici, Antonella; Spano, PierFranco; Memo, Maurizio.

In: Cellular and Molecular Neurobiology, Vol. 14, No. 5, 10.1994, p. 569-578.

Research output: Contribution to journalArticle

Pizzi, M, Valerio, A, Arrighi, V, Belloni, M, Alberici, A, Spano, P & Memo, M 1994, 'Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration', Cellular and Molecular Neurobiology, vol. 14, no. 5, pp. 569-578. https://doi.org/10.1007/BF02088838
Pizzi, Marina ; Valerio, Alessandra ; Arrighi, Virginia ; Belloni, Marco ; Alberici, Antonella ; Spano, PierFranco ; Memo, Maurizio. / Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. In: Cellular and Molecular Neurobiology. 1994 ; Vol. 14, No. 5. pp. 569-578.
@article{6932756e3eaa49d18489651b6dc6f185,
title = "Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration",
abstract = "1. We investigated the possible involvement of tau proteins in the neurotoxic process activated by glutamate using the oligonucleotide antisense strategy. 2. We found that pretreatment of granule cells with an antisense oligonucleotide of the tau gene completely prevented the increase in tau immunoreactivity induced by glutamate. 3. A significant amount of the tau antisense oligonucleotide (about 1 to 2{\%} of total) was taken up by the cells and remained stable in the cells for at least 60 min. A dose-response study revealed that 25 μM tau antisense oligonucleotide was the most efficacious concentration in terms of prevention of glutamate-induced tau immunoreactivity increases, without affecting basal tau expression. Higher concentrations of tau oligonucleotide antisense reduced tau immunoreactivity in control cells. 4. Significantly, the concentration-response curve of glutamate for inducing neuronal death in cells pretreated with tau antisense oligonucleotide showed a shift to the right compared to those obtained in untreated or tau sense oligonucleotide-treated cells. 5. Since inhibition of tau synthesis does not completely prevent but only decreases the neuronal sensitivity to glutamate, it is tempting to speculate that accumulation of tau within the neuron in response to glutamate represents one of the molecular risk factors lowering the safety margin of neurons to excitotoxic-induced injury.",
keywords = "cytoskeleton, excitatory amino acids, neurodegeneration, phosphorylation",
author = "Marina Pizzi and Alessandra Valerio and Virginia Arrighi and Marco Belloni and Antonella Alberici and PierFranco Spano and Maurizio Memo",
year = "1994",
month = "10",
doi = "10.1007/BF02088838",
language = "English",
volume = "14",
pages = "569--578",
journal = "Cellular and Molecular Neurobiology",
issn = "0272-4340",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration

AU - Pizzi, Marina

AU - Valerio, Alessandra

AU - Arrighi, Virginia

AU - Belloni, Marco

AU - Alberici, Antonella

AU - Spano, PierFranco

AU - Memo, Maurizio

PY - 1994/10

Y1 - 1994/10

N2 - 1. We investigated the possible involvement of tau proteins in the neurotoxic process activated by glutamate using the oligonucleotide antisense strategy. 2. We found that pretreatment of granule cells with an antisense oligonucleotide of the tau gene completely prevented the increase in tau immunoreactivity induced by glutamate. 3. A significant amount of the tau antisense oligonucleotide (about 1 to 2% of total) was taken up by the cells and remained stable in the cells for at least 60 min. A dose-response study revealed that 25 μM tau antisense oligonucleotide was the most efficacious concentration in terms of prevention of glutamate-induced tau immunoreactivity increases, without affecting basal tau expression. Higher concentrations of tau oligonucleotide antisense reduced tau immunoreactivity in control cells. 4. Significantly, the concentration-response curve of glutamate for inducing neuronal death in cells pretreated with tau antisense oligonucleotide showed a shift to the right compared to those obtained in untreated or tau sense oligonucleotide-treated cells. 5. Since inhibition of tau synthesis does not completely prevent but only decreases the neuronal sensitivity to glutamate, it is tempting to speculate that accumulation of tau within the neuron in response to glutamate represents one of the molecular risk factors lowering the safety margin of neurons to excitotoxic-induced injury.

AB - 1. We investigated the possible involvement of tau proteins in the neurotoxic process activated by glutamate using the oligonucleotide antisense strategy. 2. We found that pretreatment of granule cells with an antisense oligonucleotide of the tau gene completely prevented the increase in tau immunoreactivity induced by glutamate. 3. A significant amount of the tau antisense oligonucleotide (about 1 to 2% of total) was taken up by the cells and remained stable in the cells for at least 60 min. A dose-response study revealed that 25 μM tau antisense oligonucleotide was the most efficacious concentration in terms of prevention of glutamate-induced tau immunoreactivity increases, without affecting basal tau expression. Higher concentrations of tau oligonucleotide antisense reduced tau immunoreactivity in control cells. 4. Significantly, the concentration-response curve of glutamate for inducing neuronal death in cells pretreated with tau antisense oligonucleotide showed a shift to the right compared to those obtained in untreated or tau sense oligonucleotide-treated cells. 5. Since inhibition of tau synthesis does not completely prevent but only decreases the neuronal sensitivity to glutamate, it is tempting to speculate that accumulation of tau within the neuron in response to glutamate represents one of the molecular risk factors lowering the safety margin of neurons to excitotoxic-induced injury.

KW - cytoskeleton

KW - excitatory amino acids

KW - neurodegeneration

KW - phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=0028618494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028618494&partnerID=8YFLogxK

U2 - 10.1007/BF02088838

DO - 10.1007/BF02088838

M3 - Article

C2 - 7621514

AN - SCOPUS:0028618494

VL - 14

SP - 569

EP - 578

JO - Cellular and Molecular Neurobiology

JF - Cellular and Molecular Neurobiology

SN - 0272-4340

IS - 5

ER -